Analysts’ Viewpoint on Urinary Incontinence Treatment Devices Market Scenario
The number of people with urinary incontinence is increasing globally. According to a study, more than 60% women have some type of urinary incontinence. Companies are investing significantly in the development and introduction of new urinary incontinence treatment devices in order to provide the best treatment options to patients. Several market players are engaged in the development and launch of new electrical stimulation devices, such as Medtronic plc’s NURO System, for percutaneous tibial nerve stimulation for the treatment of overactive bladder. Numerous companies are offering non-invasive, over-the-counter electrical stimulation devices for incontinence. Therefore, the global urinary incontinence treatment devices market is projected to present significant opportunities for leading players in the next few years. Usage of electrical stimulation devices is increasing, as they are effective for relieving symptoms of all types of urinary incontinence, and the devices are gaining popularity as these are considered safe and effective. Therefore, new developments and technological advancements are expected to drive the global urinary incontinence treatment devices market during the forecast period.
Urinary incontinence is defined as involuntary release of urine due to loss of bladder control. Urinary incontinence devices are used for the treatment of urinary incontinence. Over 500 million people across the globe are affected by the condition and its incidence increases with age. Several factors such as urinary tract infection, weakening of pelvic floor muscles & urethral sphincters, menopause, pregnancy & childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence symptoms.
The global urinary incontinence treatment devices market size is likely to grow at a rapid pace during the forecast period. High prevalence of urinary incontinence and overactive bladder across the globe and technological advancements, such as non-implantable electrical stimulation devices, are projected to propel the global market during the forecast period.
Urinary incontinence is one of the highly prevalent and largely underreported and under diagnosed urological disorders in the world, affecting millions of people. It has a severe effect on physical, psychological, and emotional health of patients. Women are affected twice as much as men, and the incidence increases with age. Several factors such as weak pelvic floor muscles, urethral sphincters, obesity, pregnancy & childbirth, urinary tract infection, and neurological disorders cause urinary incontinence. Around 200 million people are affected by some form of urinary incontinence or bladder problems. Urinary incontinence and stress urinary incontinence are the most common forms affecting millions of people globally. Therefore, a large patient pool with stress urinary incontinence and overactive bladder symptoms is expected to augment the global urinary incontinence treatment devices market during the forecast period.
Patients undergoing radical prostectomy surgery are at a high risk of developing post prostatectomy urinary incontinence. Radical prostectomy surgery, either through radiation or surgical dissection, affects the bladder’s capacity to hold urine or causes spasms that force urine out. Additionally, radical prostectomy surgery adversely affects the nerves that control bladder function, resulting in urinary incontinence. Prostate cancer is the fourth-leading cancer affecting both men and women, and it is the second most common cancer in men followed by lung cancer. Studies have shown that the rate of stress urinary incontinence among men ranges from 2% to 69% after undergoing prostate surgery. This factor is likely to drive the global urinary incontinence treatment devices market during the forecast period.
In terms of product, the global urinary incontinence treatment devices market has been classified into urethral slings, electrical stimulation devices, artificial urinary sphincters, and catheters. The urethral slings segment has been bifurcated into female slings and male slings. The electrical stimulation devices segment has been spilt into implantable and non-implantable.
The electrical stimulation devices segment dominated the global urinary incontinence treatment devices market, with a share of around 42% in 2021. The trend is expected to continue during the forecast period. The electrical stimulation devices segment is propelled by rise in the demand for minimally invasive/wearable and non-implantable electrical stimulation devices to strengthen the pelvic floor muscles, high success rates with electrical stimulation devices, and favorable medical reimbursement policies in developed countries for implantable electrical stimulation devices.
Based on incontinence type, the global urinary incontinence treatment devices market has been segregated into stress urinary incontinence, urge urinary incontinence, mixed incontinence, and overflow incontinence. The urge incontinence segment held major share of around 40% of the global market in 2021. The trend is likely to continue during the forecast period. Growth of the segment can be attributed to higher cost of treatment devices, especially implantable electrical stimulation devices, than other treatment devices/methods such as indwelling Foley catheters. Furthermore, analysis of global urinary incontinence treatment devices market trends revealed an increase in incidence of urge incontinence, rise in adoption of electrical stimulation devices for overactive bladder treatment, and new product launches are likely to propel the segment during the forecast period.
In terms of end-user, the global urinary incontinence treatment devices market has been divided into hospitals, ambulatory surgery centers, clinics, and home use. The hospitals segment held major share of around 60% of the global market in 2021. Growth of the segment can be attributed to increase in the number of surgical procedures for the treatment of all types of urinary incontinence and favorable reimbursement policies for medical devices in most of the developed and developing countries.
North America accounted for the largest global urinary incontinence treatment devices market share of around 42% in 2021. Early adoption of technologies, large patient pool of urinary incontinence, and easy availability & lucrative medical reimbursement policies in the U.S. and Canada are attributed to North America’s prominent market share in 2021.
Europe held around 32% share of the global market in 2021. The market in the region grew at a faster growth rate in 2021 owing to high prevalence and increase in incidence of urinary incontinence, surge in adoption of technologically advanced products, large base of medical device companies, and high number of products in pipeline for the treatment of urinary incontinence.
Asia Pacific held larger share of the global urinary incontinence treatment devices market than Latin America and Middle East & Africa. However, the market in Latin America is likely to grow at a faster pace than in Middle East & Africa.
The urinary incontinence treatment devices market report concludes with the company profiles section, which includes key information about major players in the global urinary incontinence treatment devices market. Leading players in the global urinary incontinence treatment devices market include C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, Promedon Group, A.M.I. GmbH, Ethicon US, LLC. (Johnson & Johnson), ZSI Surgical Implants S.R.L., Medtronic plc, InControl Medical LLC, Hollister Incorporated, Atlantic Therapeutics Group Ltd., B. Braun Melsungen AG, and Teleflex Incorporated.
Each of these players has been profiled in the urinary incontinence treatment devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 2.7 Bn |
|
Market Forecast Value in 2031 |
More than US$ 5.5 Bn |
|
Growth Rate (CAGR) for 2022-2031 |
7.7% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global urinary incontinence treatment devices market was valued at US$ 2.7 Bn in 2021.
The global urinary incontinence treatment devices market is projected to reach more than US$ 5.5 Bn by 2031.
The global urinary incontinence treatment devices market is anticipated to grow at a CAGR of 7.7% from 2022 to 2031.
The electrical stimulation devices segment held around 42% share of the global urinary incontinence treatment devices market in 2021.
North America is expected to account for major share of the global market during the forecast period.
C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, Promedon Group, A.M.I. GmbH, Ethicon US, LLC. (Johnson & Johnson), ZSI Surgical Implants S.R.L., Medtronic plc, InControl Medical LLC, Hollister Incorporated, Atlantic Therapeutics Group Ltd., B. Braun Melsungen AG, and Teleflex Incorporated.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Urinary Incontinence Treatment Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Prevalence of Urinary Incontinence, by Key Region
5.3. Regulatory & Reimbursement Scenario, by Country/Region
5.4. COVID-19 Impact Analysis
6. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Urethral Slings
6.3.1.1. Female Slings
6.3.1.2. Male Slings
6.3.2. Electrical Stimulation Devices
6.3.2.1. Implantable
6.3.2.2. Non-implantable
6.3.3. Artificial Urinary Sphincters
6.3.4. Catheters
6.4. Market Attractiveness Analysis, by Product
7. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Incontinence Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Incontinence Type, 2017–2031
7.3.1. Stress Urinary Incontinence
7.3.2. Urge Urinary Incontinence
7.3.3. Mixed Incontinence
7.3.4. Overflow Incontinence
7.4. Market Attractiveness Analysis, by Incontinence Type
8. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Clinics
8.3.4. Home Use
8.4. Market Attractiveness Analysis, by End-user
9. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Urinary Incontinence Treatment Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Urethral Slings
10.2.1.1. Female Slings
10.2.1.2. Male Slings
10.2.2. Electrical Stimulation Devices
10.2.2.1. Implantable
10.2.2.2. Non-implantable
10.2.3. Artificial Urinary Sphincters
10.2.4. Catheters
10.3. Market Value Forecast, by Incontinence Type, 2017–2031
10.3.1. Stress Urinary Incontinence
10.3.2. Urge Urinary Incontinence
10.3.3. Mixed Incontinence
10.3.4. Overflow Incontinence
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Clinics
10.4.4. Home Use
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Incontinence Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Urinary Incontinence Treatment Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Urethral Slings
11.2.1.1. Female Slings
11.2.1.2. Male Slings
11.2.2. Electrical Stimulation Devices
11.2.2.1. Implantable
11.2.2.2. Non-implantable
11.2.3. Artificial Urinary Sphincters
11.2.4. Catheters
11.3. Market Value Forecast, by Incontinence Type, 2017–2031
11.3.1. Stress Urinary Incontinence
11.3.2. Urge Urinary Incontinence
11.3.3. Mixed Incontinence
11.3.4. Overflow Incontinence
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Clinics
11.4.4. Home Use
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Incontinence Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Urinary Incontinence Treatment Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Urethral Slings
12.2.1.1. Female Slings
12.2.1.2. Male Slings
12.2.2. Electrical Stimulation Devices
12.2.2.1. Implantable
12.2.2.2. Non-implantable
12.2.3. Artificial Urinary Sphincters
12.2.4. Catheters
12.3. Market Value Forecast, by Incontinence Type, 2017–2031
12.3.1. Stress Urinary Incontinence
12.3.2. Urge Urinary Incontinence
12.3.3. Mixed Incontinence
12.3.4. Overflow Incontinence
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Clinics
12.4.4. Home Use
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Incontinence Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Urinary Incontinence Treatment Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Urethral Slings
13.2.1.1. Female Slings
13.2.1.2. Male Slings
13.2.2. Electrical Stimulation Devices
13.2.2.1. Implantable
13.2.2.2. Non-implantable
13.2.3. Artificial Urinary Sphincters
13.2.4. Catheters
13.3. Market Value Forecast, by Incontinence Type, 2017–2031
13.3.1. Stress Urinary Incontinence
13.3.2. Urge Urinary Incontinence
13.3.3. Mixed Incontinence
13.3.4. Overflow Incontinence
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Clinics
13.4.4. Home Use
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Incontinence Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Urinary Incontinence Treatment Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Urethral Slings
14.2.1.1. Female Slings
14.2.1.2. Male Slings
14.2.2. Electrical Stimulation Devices
14.2.2.1. Implantable
14.2.2.2. Non-implantable
14.2.3. Artificial Urinary Sphincters
14.2.4. Catheters
14.3. Market Value Forecast, by Incontinence Type, 2017–2031
14.3.1. Stress Urinary Incontinence
14.3.2. Urge Urinary Incontinence
14.3.3. Mixed Incontinence
14.3.4. Overflow Incontinence
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Clinics
14.4.4. Home Use
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Incontinence Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. C. R. Bard, Inc. (Becton, Dickinson and Company)
15.3.1.1. Company Description
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. Coloplast Group
15.3.2.1. Company Description
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Promedon Group
15.3.3.1. Company Description
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. A.M.I. GmbH
15.3.4.1. Company Description
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Ethicon US, LLC. (Johnson & Johnson)
15.3.5.1. Company Description
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. ZSI Surgical Implants S.R.L.
15.3.6.1. Company Description
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Medtronic plc
15.3.7.1. Company Description
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. InControl Medical LLC
15.3.8.1. Company Description
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
15.3.9. Hollister Incorporated
15.3.9.1. Company Description
15.3.9.2. Business Overview
15.3.9.3. Financial Overview
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
15.3.10. Atlantic Therapeutics Group Ltd.
15.3.10.1. Company Description
15.3.10.2. Business Overview
15.3.10.3. Financial Overview
15.3.10.4. Strategic Overview
15.3.10.5. SWOT Analysis
15.3.11. B. Braun Melsungen AG
15.3.11.1. Company Description
15.3.11.2. Business Overview
15.3.11.3. Financial Overview
15.3.11.4. Strategic Overview
15.3.11.5. SWOT Analysis
15.3.12. Teleflex Incorporated
15.3.12.1. Company Description
15.3.12.2. Business Overview
15.3.12.3. Financial Overview
15.3.12.4. Strategic Overview
15.3.12.5. SWOT Analysis
List of Tables
Table 01: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 03: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 04: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 08: North America Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 12: Europe Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 16: Asia Pacific Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 20: Latin America Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 24: Middle East & Africa Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
Figure 02: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 03: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Urethral Slings, 2017–2031
Figure 04: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Electrical Stimulation Devices, 2017–2031
Figure 05: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Artificial Urinary Sphincters, 2017–2031
Figure 06: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Catheters, 2017–2031
Figure 07: Global Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
Figure 08: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031
Figure 09: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Stress Urinary Incontinence, 2017–2031
Figure 10: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Urge Urinary Incontinence, 2017–2031
Figure 11: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Mixed Incontinence, 2017–2031
Figure 12: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Overflow Incontinence, 2017–2031
Figure 13: Global Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
Figure 14: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 15: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Hospitals, 2017–2031
Figure 16: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Ambulatory Surgery Centers, 2017–2031
Figure 17: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Clinics, 2017–2031
Figure 18: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Home Use, 2017–2031
Figure 19: Global Urinary Incontinence Treatment Devices Market Value Share Analysis, by Region, 2021 and 2031
Figure 20: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Region, 2022–2031
Figure 21: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 22: North America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country, 2021 and 2031
Figure 23: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country, 2022–2031
Figure 24: North America Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
Figure 25: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 26: North America Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
Figure 27: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031
Figure 28: North America Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
Figure 29: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 30: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 31: Europe Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 32: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 33: Europe Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
Figure 34: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 35: Europe Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
Figure 36: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031
Figure 37: Europe Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
Figure 38: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 39: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 40: Asia Pacific Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 41: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 42: Asia Pacific Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
Figure 43: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 44: Asia Pacific Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
Figure 45: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031
Figure 46: Asia Pacific Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
Figure 47: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 48: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 49: Latin America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 50: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 51: Latin America Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
Figure 52: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 53: Latin America Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
Figure 54: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031
Figure 55: Latin America Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
Figure 56: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 57: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 58: Middle East & Africa Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 59: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 60: Middle East & Africa Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
Figure 61: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 62: Middle East & Africa Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
Figure 63: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031
Figure 64: Middle East & Africa Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
Figure 65: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Urinary Incontinence Treatment Devices Market
